Skip to main content
# Title Department Research Member Research Year
1 Analysis of chest wall breathing motion, setup accuracy and dosimetric stability of VMAT technique radiation therapy in breast cancer patients Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed July 2021
2 Evaluation of Safety and Efficacy of 1 week versus 3 weeks hypofractionation radiotherapy for breast cancer patients: Phase III trial Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed January2023(1):
3 Beta Endorphins, Interleukin 1 and Interleukin 38 in Covid Patients Associated with Neuropsychological Manifestations Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2024
4 Exploring the efficacy of various wheat bran extracts in promoting burn wound healing: A comparative analysis Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2024
5 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine ِAya AbdelBaset Ahmed 2024
6 Beta Endorphins, Interleukin 1 and Interleukin 38 in Covid Patients Associated with Neuropsychological Manifestations Department of Clinical Pathology Dr. Engy adel shafeek 2024
7 Diagnostic efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2024
8 Analgesic effect of nulbuphine -bupivacaine combination in ultrasound guided Transverses abdominis plane block in patients undergoing major abdominal cancer surgeries. Department of Anesthesia, Intensive care and Pain management Dr. Shereen Mamdoh Mohamed kamal 2024
9 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
10 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024